Vanguard Fiduciary Trust
IPSC icon

Vanguard Fiduciary Trust’s Century Therapeutics IPSC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Buy
737,522
+44,559
+6% +$102K ﹤0.01% 2724
2026
Q1 		$1.57M Buy
+692,963
New +$1.46M ﹤0.01% 2696

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Fiduciary Trust's IPSC Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Century Therapeutics (IPSC) stake by 6.4% in Q2 2026, buying an estimated $102K and bringing the position to 737,522 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

Vanguard Fiduciary Trust first reported a position in IPSC in Q1 2026 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Vanguard Fiduciary Trust held 737,522 shares of Century Therapeutics worth $1.81M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 44,559 Century Therapeutics shares in Q2 2026, an estimated $102K.
  • Century Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2724 holding.
  • Vanguard Fiduciary Trust first reported a position in Century Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.